Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.

Mohammedi I; Ploin D; Duperret S; Chapuis F; Petit P

首页> 外文期刊>Intensive care medicine >Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.

【24h】

Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.

机译：ICU患者中对哌拉西林/他唑巴坦耐药的大肠杆菌的危险因素：一项临床研究。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: To determine risk factors of infections with piperacillin/tazobactam-resistant Escherichia coli in critical care patients. DESIGN: Prospective, consecutive sample survey study. SETTING: Surgical intensive care unit (ICU) in a university hospital. PATIENTS: A consecutive series of 133 patients from whom culture results were positive for E. coli during their ICU stay. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Multivariate logistic regression analysis identified the following significant independent factors associated with the emergence of a piperacillin/tazobactam-resistant Escherichia coli: prior use of amoxicillin (odds ratio, 4.15) and amoxicillin/clavulanate (odds ratio, 3.25). CONCLUSIONS: Treatment with amoxicillin or amoxicillin/clavulanate is a major risk factor for the detection of piperacillin/tazobactam-resistant E. coli in ICU patients.

机译：目的：确定危重病人耐哌拉西林/他唑巴坦的大肠杆菌感染的危险因素。设计：前瞻性，连续样本调查研究。地点：大学医院的外科重症监护室（ICU）。患者：连续133例患者在ICU住院期间培养结果为大肠杆菌阳性。干预措施：无。测量和主要结果：多元逻辑回归分析确定了下列与哌拉西林/他唑巴坦耐药的大肠杆菌的出现相关的重要独立因素：先前使用阿莫西林（比值为4.15）和阿莫西林/克拉维酸（比值为3.25）。结论：阿莫西林或阿莫西林/克拉维酸盐治疗是ICU患者检测哌拉西林/他唑巴坦耐药大肠杆菌的主要危险因素。

著录项

来源
《Intensive care medicine》 |2003年第7期|共5页
作者
Mohammedi I; Ploin D; Duperret S; Chapuis F; Petit P;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词
Intensive Care Units; Escherichia coli; Piperacillin with tazobactam; Risk Factors; 加强医疗病房; 大肠杆菌; 危险因素; 阿莫西林;

机译：Intensive Care Units;Escherichia coli;Piperacillin with tazobactam;Risk Factors;加强医疗病房;大肠杆菌;危险因素;阿莫西林;

相似文献

外文文献
中文文献
专利

1. Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study. [J] . Mohammedi I, Ploin D, Duperret S, Intensive care medicine . 2003,第7期

机译：ICU患者中对哌拉西林/他唑巴坦耐药的大肠杆菌的危险因素：一项临床研究。
2. Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study. [J] . Lee G, Cho YH, Shim BS, Journal of Korean medical science . 2010,第8期

机译：从韩国急性非复杂性膀胱炎患者中分离出的大肠杆菌菌株中抗菌素耐药性的危险因素：一项前瞻性和全国性研究。
3. Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study. [J] . Lee G, Cho YH, Shim BS, Journal of Korean medical science . 2010,第8期

机译：从韩国急性非复杂性膀胱炎患者中分离出的大肠杆菌菌株中抗菌素耐药性的危险因素：一项前瞻性和全国性研究。
4. Virulence Factors and Antibiotic Resistance Among Escherichia coli Isolates from Danish Dairy Cattle with Clinical Mastitis [C] . Annual Meeting of The National Mastitis Council . 2020

机译：来自丹麦乳制牛与临床乳腺炎的大肠杆菌中的毒力因子和抗生素抗性
5. Spatial, temporal and management-specific factors influencing antibiotic resistance and carbohydrate fermentation patterns in bovine enteric Escherichia coli and the clinical consequences of limiting antibiotic use in pre-weaned calves [D] . Berge, Anna Catharina Bjornsdotter 2004

机译：影响牛肠大肠杆菌中抗生素抗药性和碳水化合物发酵模式的时空，管理和特定因素，以及断奶前犊牛限制使用抗生素的临床后果
6. Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study [O] . Agnès Meybeck, Jean-Damien Ricard, Guilène Barnaud, 2008

机译：ICU中对哌拉西林/他唑巴坦耐药的大肠杆菌感染的发生率及其对临床结局的影响：一项回顾性研究
7. P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiographyP1247Surgical therapy in infective endocarditis: predisposing and prognostic factorsP1248Evalutation of MV annulus geometry modifications before and after mitraclip implantation with 3D transesophageal echocardiographyP1249Prognostic echocardiographic parameters for successful transcatheter edge-to-edge mitral valve repairP1250Influence of body surface area in diagnosis and outcome patient-prosthesis mismatch after TAVI. Is it necessary to adjust for ideal body weight?P1251Outcome of paradoxical low-flow low-gradient severe AS following TAVI: paradoxical VS parallel to outcome of high gradient ASP1252Prognostic role of cardiac calcifications in subjects without overt significant heart disease and previous cardiovascular events: is there an additive value over cardiovascular risk factors scores?P1253Aging degeneration of mitral valve without leaflet prolapse or tethering as a cause of severe mitral regurgitationP1254Cardiovascular risk assessment should be performed in patients with incidental aortic sclerosisP1255Cardiac valve calcification score: simple 2D echocardiographic tool for cardiovascular risk stratification in patients with chronic renal failureP1256Diastolic mitral regurgitation following transcatheter aortic valve replacement: prevalence, predictors and impact on outcomesP1257Timing of myocardial shortening determines left ventricular regional remodelling in hearts with conduction delaysP1258Myocardial stiffness assessment using shear wave imaging in healthy children and hypertrophic cardiomyopathyP1259Assessment of right ventricular response to exercise using vector velocity imaging in hypertrophic cardiomyopathyP1260Diagnostic value of cardiac biomarkers (high sensitive troponin T and N-terminal pro-brain natriuretic peptide) in patients with infiltrative cardiomyopathiesP1261Right ventricular global longitudinal strain differentiates between adolescent patients with definite, borderline and possible ARVC and controlsP1262 echogrqphic predictif factors of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasiaP1263Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fractionP1264Chronotropic response in mitochondrial (ANT1) cardiomyopathyP1265 The effect of cardiovascular risk factors and cancer type in anthracycline's cardiotoxicityP1266Revisiting the echocardiographic features of acute myocarditisP1267Altered circulation in fetuses of diabetic mothers: a fetal computational model analysisP1268Increased epicardial adipose tissue is related to stress-induced cardiomyopathyP1269Contrast enhanced ultrasound of kidney perfusion in patients with renal artery stenosis: diagnostic and prognostic applications. [O] . F. Ancona, R. Ilhao Moreira, V. Lavanco, 2016

机译：P1246age-，身体大小和性别特异性参考Tricuspid阀装置参数通过实时三维经线性超声心动图124772777777747774747478EVALIGUTALMEXP1249预期植入前后MV环形植入前后MV环空性修饰。超声心动图参数用于成功的经截管边缘到边缘二尖瓣修复P1250中的体表面积诊断和结果患者假体在Tavi后的不匹配。是否有必要调整理想的体重？P1251矛盾的低流量低梯度严重，如Tavi：矛盾的VS平行于高梯度ASP1252的结果，在没有明显显着的心脏病和以前心血管事件的情况下心脏钙化的促傲作用患有心血管危险因素的添加剂值分数？没有传单脱垂的二尖瓣退化或作为严重二尖瓣血管血管血管病风险评估的患者进行脱垂或系绳，应当在偶然主动脉源肺源P1255Cariac阀钙化评分患者中进行：用于心血管风险分层的简单2D超声心动图工具在慢性肾功能衰竭的患者中，经沟管主动脉瓣膜置换术后：流行率，预测因子和对Otcomasp1257的影响，心肌缩短决定了导通延迟的心中的剩余心室区域重新耦合258MYCIARIAL僵硬评估使用剪切波成像在健康儿童和肥厚性心肌脑病中的舒缓性心脏响应，在渗透心肌肌瘤患者中使用载体速度成像的培养速度成像（高敏感的肌钙蛋白T和N-末端脑Natrietic肽）渗透心肌病，患者心室全局纵向菌株在患有心律失常右心室发育不良患者的心理心律失常患者中的青少年患者与Controlsp1262 echogrqphic预测因子的分歧，患者心血性右心室发育不良患者患者患者患者患者患者患者患者患者患者线粒体（ANT1）心肌病患者的喷射FRACTIONP1264系列响应1265心血管危险因素和癌症类型在蒽丙烯的心肌毒性皮1126660中的影响访问患有糖尿病母亲胎儿胎儿急性心肌炎的超声心动图，患者患者：胎儿计算模型分析P1268增加外膜脂肪组织与肾动脉狭窄患者肾脏灌注的应激诱导的心肌病，增强超声波：诊断和预后应用。

Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.

摘要

著录项

相似文献

相关主题

期刊订阅